latest news releases from the newsroom
Skanska Adapts Internal Control to New Corporate Code
STOCKHOLM, Sweden, Sept. 6, 2005 (PRIMEZONE) -- Skanska's Group Staff Controlling is responsible for business control support for the Senior Executive Team. This staff has now been assigned extended responsibility for establishing the internal control function prescribed by the new Swedish Code of Corporate Governance. Mariann Ostansjo has been appointed Senior Vice President for the staff unit.
J.P. Morgan Chase & Co.'s Holdings in Metso to 4.91 Percent
HELSINKI, Finland, Sept. 6, 2005 (PRIMEZONE) -- Metso Corporation has been informed about a decrease in the holding of the mutual funds managed by J.P. Morgan Chase & Co. of the paid up share capital of Metso Corporation. On September 1, 2005, J.P. Morgan Chase & Co 's holdings amounted to 4.91 percent of the paid up share capital of Metso Corporation after being, on the basis of their previous announcement, 5.04 percent on August 23, 2005. The holding fell below the threshold of five percent on September 1, 2005 when J.P. Morgan Asset Management (U.K.) Limited acting as a discretionary investment manager for underlying funds sold 174,502 Metso shares.
Atlas Copco to Acquire Compressed Natural Gas Compressor Manufacturer in New Zealand
STOCKHOLM, Sweden, Sept. 6, 2005 (PRIMEZONE) -- A new subsidiary of Atlas Copco South Pacific Holdings Pty Limited, Australia, has agreed to acquire Intermech Ltd., based in New Zealand, in order to extend its product offering into a growing business. The turnover for Intermech (April 2004 -- March 2005) was close to MSEK 100 and it has 45 employees. The purchase price is not disclosed.
Petroleum Geo-Services ASA
PGS to Convert 4C Crew to Streamer Vessel Operations
OSLO, Norway, Sept. 6, 2005 (PRIMEZONE) -- Petroleum Geo-Services ASA ("PGS" or the "Company") (OSE:PGS) (NYSE:PGS) announced today that it has decided to convert its current 4C Ocean Bottom Crew operation, including the vessels Ocean Explorer and Falcon, to towed streamer vessels. The third vessel used in this operation, Bergen Surveyor, is on a short term lease and will be returned to its owners. The conversion is expected to start around year end 2005. No personnel reductions are expected.
First Patient Treated in Extended Phase I Trial of Antisoma's AS1411
LONDON, Sept. 6, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma (LSE:ASM) announces that it has reopened a U.S. phase I trial of its aptamer drug AS1411 following the presentation of promising data at this year's American Society of Clinical Oncology meeting. The study is now enrolling patients with renal and non-small cell lung cancers. Signs of anti-cancer activity were seen in all of the three renal cancer patients included in the original trial, and Antisoma has recently been granted U.S. orphan drug status for AS1411 in renal cancer.